Abstract |
In a multicentre, double-blind, randomized, parallel group study in general practice, 269 patients with clinically diagnosed fungal infection of the skin were treated with either naftifine (Exoderil) or 1% clotrimazole plus 1% hydrocortisone (CHC; Canesten HC) applied twice daily for 4 weeks. Only 115 patients were shown subsequently to have a fungal infection by laboratory tests; the others had inflammatory disease of unknown aetiology. In those with fungal disease, both treatments were equally effective in terms of mycological cure (negative microscopy and culture). Clinical results for all 265 patients showed no clinically identifiable difference between the two preparations in terms of resolution of the disease, indicating that naftifine does have anti-inflammatory activity at least equal to CHC. This study suggests that there is no clinical advantage in treating patients with clinically diagnosed fungal infection of the skin with an antimycotic/ corticosteroid combination as opposed to naftifine alone.
|
Authors | E G Evans, I G James, R A Seaman, M D Richardson |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 129
Issue 4
Pg. 437-42
(Oct 1993)
ISSN: 0007-0963 [Print] England |
PMID | 8217759
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antifungal Agents
- Drug Combinations
- Allylamine
- naftifine
- Clotrimazole
- Hydrocortisone
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Aged
- Allylamine
(analogs & derivatives, therapeutic use)
- Anti-Inflammatory Agents
(therapeutic use)
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Antifungal Agents
(therapeutic use)
- Child
- Clotrimazole
(therapeutic use)
- Dermatomycoses
(drug therapy)
- Double-Blind Method
- Drug Combinations
- Female
- Humans
- Hydrocortisone
- Male
- Middle Aged
|